Discovery of proangiogenic CD44+mesenchymal cancer stem cells in an acute myeloid leukemia patient’s bone marrow
Open Access
- 3 June 2020
- journal article
- letter
- Published by Springer Nature in Journal of Hematology & Oncology
- Vol. 13 (1) , 1-4
Abstract
Here, we report a unique acute myeloid leukemia (AML) bone marrow-derived mesenchymal stem cell (MSC) with both mesenchymal and endothelial potential, which we have named Mesenchymal Cancer Stem Cells (MCSCs). These MCSCs are CD90-CD13-CD44+ and differ from MSCs in isolation, expansion, differentiation, immunophenotype, and cytokine release profile. Furthermore, blocking CD44 inhibited the proliferation and cluster formation of early MCSCs with lower ICAM-1 protein levels. Similar CD90-CD44+ cancer stem cells have been reported in both gastric and breast cancers, which grew in floating spheres in vitro and exhibited mesenchymal features and high metastatic/tumorigenic capabilities in vivo. Our novel discovery provides the first evidence that certain AMLs may be comprised of both hematopoietic and stromal malignant cells. Targeting MCSCs and their cytokine release has potential as a novel therapeutic approach in AML.Keywords
Funding Information
- Loma Linda University (RIG, GRASP)
This publication has 10 references indexed in Scilit:
- Very poor long‐term survival in past and more recent studies for relapsed AML patients: The ECOG‐ACRIN experienceAmerican Journal of Hematology, 2018
- Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretionLeukemia, 2017
- Acute myeloid leukemia in the older adultsLeukemia Research Reports, 2016
- Big data analysis of treatment patterns and outcomes among elderly acute myeloid leukemia patients in the United StatesAnnals of Hematology, 2015
- Functional integration of acute myeloid leukemia into the vascular nicheLeukemia, 2014
- Leukaemogenesis induced by an activating β-catenin mutation in osteoblastsNature, 2014
- c-Met recruits ICAM-1 as a coreceptor to compensate for the loss of CD44 inCd44null miceMolecular Biology of the Cell, 2011
- The Chemokine Network in Acute Myelogenous Leukemia: Molecular Mechanisms Involved in Leukemogenesis and Therapeutic Implications2010
- Bone progenitor dysfunction induces myelodysplasia and secondary leukaemiaNature, 2010
- Subclassification of patients with acute myelogenous leukemia based on chemokine responsiveness and constitutive chemokine release by their leukemic cellsHaematologica, 2007